Mastifin®

Intramammary antimicrobial made from Gentamicin for bovine.

Therapeutic
  • Bovinos
  • Market leader.
  • Treatment of acute or chronic mastitis.
  • Administered through the intramammary route.

Components

Each 10 g syringe contains:

Gentamicin (as a Sulfate)* ......... 150.00 mg

Excipient q.s. ........................................ 10.00 g

*Corresponds to 254.24 mg of Gentamicin Sulfate


Indicações:

Mastifin® is indicated for the treatment of bovine mastitis, caused by microorganisms sensitive to Gentamycin, such as: Corynebacterium bovis, Enterobacter aerogenes, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus agalactiae, Streptococcus uberis, Streptococcus dysgalactiae and Trueperella pyogenes.


Directions and Dosage:

Perform, when needed, the washing of the udder and proceed with the handling of cleaning through pre-dipping. After the milking apply through the intramammary route, the whole content of 1 syringe, which is, 10 g of Mastifin® in each affected quarter. After the application, for a better dispersion of the product at the mammary gland, it is recommended to massage the udder from bottom to top.

After the use of the product, clean the udder post-milking, through pre-dipping. Mastifin® must be applied in each affected quarter for three consecutive days, with 24-hour intervals between applications.


CAUTION: COMPLY WITH THE FOLLOWING GRACE PERIODS

BOVINE

Slaughter: the slaughter of the animals treated with this product must only be carried out 22 days after the last application.

Milk: the milk of the animals treated with this product must not be intended for human consumption for up to 7.5 days after the last application of this product.


Last update: 10-31-2023

Presentations:

  • Display with 24 disposable plastic syringes containing 10 g